WHO ICTRP trial
Randomized controlled prospective study on treatment of mild COVID-19 with…
ITMCTR2200006038 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Recruiting
Key facts
| Trial ID | ITMCTR2200006038 |
|---|---|
| Public title | Randomized controlled prospective study on treatment of mild COVID-19 with Qinghua Bihui Granules |
| Scientific title | Randomized controlled prospective study on treatment of mild COVID-19 with Qinghua Bihui Granules |
| Primary sponsor | Jiujiang Hospital of Traditional Chinese Medicine |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | china |
| Conditions | Novel Coronavirus Pneumonia (COVID-19) |
| Interventions | experimental group:Western medicine basic treatment + Qinghua Bihui Granules;control group:Western medicine basic treatment |
| Registration date | May 26, 2022 |
| Target size | experimental group:250;control group:250 |
| Secondary IDs | ChiCTR2200060294;ChiMCTR2200006038 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: